Cargando…

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies

Combinatorial biology methods offer a good solution for targeting interactions of specif ic molecules by a high-throughput screening and are widely used for drug development, diagnostics, identif ication of novel monoclonal antibodies, search for linear peptide mimetics of discontinuous epitopes for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chikaev, A.N., Rudometov, A.P., Merkulyeva, Yu.A., Karpenko, L.I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453360/ https://www.ncbi.nlm.nih.gov/pubmed/34595378 http://dx.doi.org/10.18699/VJ21.063

Ejemplares similares

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
por: Rudometov, Andrey P., et al.
Publicado: (2019)

Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01
por: Chikaev, Anton N., et al.
Publicado: (2015)

P05-02. Including peptides-mimotopes of neutralizing 2F5 epitope of HIV-1 into artificial peptide TBI – vaccine candidate
por: Scherbakova, NS, et al.
Publicado: (2009)

P19-13. Recombinant proteins carrying peptide mimics of HIV-1
por: Chikaev, A, et al.
Publicado: (2009)

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
por: Rudometova, N.B., et al.
Publicado: (2022)

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
por: Jia, Manxue, et al.
Publicado: (2020)

shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
por: Subrakova, V.G., et al.
Publicado: (2020)

VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
por: Kulemzin, Sergey V., et al.
Publicado: (2022)

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research
por: Williamson, Brian D., et al.
Publicado: (2023)

Phage Display Selection of an Anti-Idiotype-Antibody with Broad-Specificity to Deoxynivalenol Mycotoxins
por: Leivo, Janne, et al.
Publicado: (2020)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies
por: Cheeseman, Hannah M., et al.
Publicado: (2016)

Antibody Phage Display
por: Aitken, Rob
Publicado: (2008)

Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses
por: Anand, Taruna, et al.
Publicado: (2021)

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
por: Byazrova, Maria G., et al.
Publicado: (2022)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
por: Gorchakov, Andrey A., et al.
Publicado: (2021)

Characterization of Murine Coronavirus Neutralization Epitopes with Phage-Displayed Peptides
por: Yu, Mathilde W.N., et al.
Publicado: (2000)

Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
por: Hioe, Catarina E., et al.
Publicado: (2010)

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
por: Spencer, David A., et al.
Publicado: (2021)

In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a Semi-Immune Phage Display Library
por: González-González, Edith, et al.
Publicado: (2022)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Broad neutralization coverage of HIV by multiple highly potent antibodies
por: Walker, Laura M., et al.
Publicado: (2011)

Detection of Bacterial Pathogens by Phage Antibody Display
por: Pai, Namrata, et al.
Publicado: (2000)

High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries
por: Chen, Ing-Chien, et al.
Publicado: (2017)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

bNAber: database of broadly neutralizing HIV antibodies
por: Eroshkin, Alexey M., et al.
Publicado: (2014)

Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017)

Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1
por: Omorodion, Oluwarotimi, et al.
Publicado: (2021)

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
por: Sok, Devin, et al.
Publicado: (2017)

Bioinformatics Resources and Tools for Phage Display
por: Huang, Jian, et al.
Publicado: (2011)

Basics of Antibody Phage Display Technology
por: Ledsgaard, Line, et al.
Publicado: (2018)

Phage Display Libraries Identify T Cells
Publicado: (2004)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vgbdsebj62a5pkpgo367tet3dm